Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial
- Citation:
- J Clin Oncol vol 28 (23) 3673-3679
- Year:
- 2010
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- 822
- Children:
- None
- Program:
- CCP
- Primary Committee:
- Symptom Inter
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- A. R. Moraska A. Sood S. R. Dakhil J. A. Sloan D. Barton P. J. Atherton J. J. Suh P. C. Griffin D. B. Johnson A. Ali P. T. Silberstein S. F. Duane C. L. Loprinzi
- Networks:
- Study
- NCCTG-N05C7
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: